Department of Defense HIV/AIDS Prevention Program
ID: 343653Type: Posted
Overview

Buyer

Dept. of the Army -- USAMRAA (DOD-AMRAA)

Eligible Applicants

Unrestricted

Funding Category

Health

Funding Instrument

Cooperative Agreement

Opportunity Category

Discretionary

Cost Sharing or Matching Requirement

Yes

Original Source

https://grants.gov/search-results-detail/343653
Timeline
    Description

    The Department of the Army, through the US Army Medical Research and Materiel Command (USAMRAA), is offering a federal grant opportunity titled the Department of Defense HIV/AIDS Prevention Program (DHAPP). This program aims to save lives and prevent HIV infections by supporting the development of interventions and programs within military health systems, particularly in foreign countries, to achieve effective HIV/AIDS epidemic control. The initiative emphasizes collaboration with military partners to create tailored plans that address specific HIV/AIDS challenges, focusing on prevention, care, and treatment aligned with national strategies and the PEPFAR goals of 90-90-90 and 95-95-95. Interested applicants can apply for one of the seven expected awards, with no cost-sharing requirements, and must submit their proposals by September 18, 2027. For further inquiries, potential applicants can contact Ebony Simmons at ebony.s.simmons.civ@health.mil or by phone at 301-619-2105.

    Files
    Title
    Posted
    SOW_DHAPP TEMPLATE for Proposal Submission_Y1.xlsx
    The document outlines a budget submission template for a federal agency's intervention programs, indicating requirements for data entry and budget categorization. It specifies that entries should only occur in designated green cells, with detailed instructions on how to populate various sections, including program area selections and beneficiary identification. The template highlights that all budgeted amounts should be zero, pointing to an initial proposal stage or lack of financial allocation at this time.
    SOW_DHAPP TEMPLATE for Proposal Submission_Y2-Y4.xlsx
    The document outlines a budget template related to interventions with the Department of Defense (DOD), including data entry instructions for various phases and years, indicating a current total budget of $0 for all listed interventions. It includes details on required metadata such as organization names, funding sources, and categorization of interventions, while highlighting the management of program areas and beneficiaries. The instructions emphasize strict data entry constraints to maintain integrity across budget submissions and reporting.
    SOW_DHAPP.bin
    Similar Opportunities
    Microbicides Research, Development, and Introduction
    Agency for International Development
    The U.S. Agency for International Development (USAID) is offering a federal grant opportunity titled "Microbicides Research, Development, and Introduction" aimed at advancing research and innovative activities related to microbicides for HIV prevention. This initiative seeks to support clinical trials and other activities that contribute to the Global Health Initiative's principles, particularly focusing on a woman- and girl-centered approach and strengthening health systems. The funding amounts range from $100,000 to $2,250,000, with no cost-sharing or matching requirements, and interested applicants can contact Kathleen Bumpass at kbumpass@usaid.gov for further information. The closing date for applications is to be determined.
    Capacity Building to sustain HIV epidemic control under PEPFAR
    Health Resources and Services Administration
    The Health Resources and Services Administration (HRSA) is forecasting a federal grant opportunity titled "Capacity Building to sustain HIV epidemic control under PEPFAR." This initiative aims to establish a network of organizations that will provide tailored technical assistance to support the accelerated and sustained control of the HIV epidemic across PEPFAR countries. The program is critical for enhancing health outcomes and ensuring effective responses to the HIV epidemic, with an estimated total funding of $2 million available for approximately five awards. Interested applicants, including public and private entities, can reach out to the Office of Global Health at HRSA via email at hrsa@hrsa.gov or by phone at 301-443-0000, with the synopsis expected to be posted on February 20, 2025, and applications closing on May 21, 2025.
    Addressing Stigma to End the HIV Epidemic in the U.S.
    Health Resources and Services Administration
    The Health Resources and Services Administration (HRSA) is offering a funding opportunity titled "Addressing Stigma to End the HIV Epidemic in the U.S." aimed at supporting an organization that will implement, train, and evaluate anti-stigma interventions to enhance access to HIV care for underserved populations. The selected recipient will manage approximately 20 demonstration sites, facilitate national training, and develop a robust evaluation framework to assess the impact of these interventions over a four-year performance period, with a total funding amount of $25.25 million. This initiative is crucial for improving health outcomes by reducing stigma within healthcare systems, thereby increasing the availability of high-quality care, treatment, and prevention services for individuals affected by HIV. Interested applicants, including public and private nonprofits, state and local governments, and educational institutions, must submit their proposals by March 18, 2025, with the funded program expected to commence on September 1, 2025. For further inquiries, contact LaQuanta Smalley at SPNS@hrsa.gov.
    Innovation for HIV Vaccine Discovery (R01 Clinical Trial Not Allowed)
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a grant opportunity titled "Innovation for HIV Vaccine Discovery" (NOFO Number PAR-23-169) aimed at supporting high-risk, high-impact early discovery research focused on innovative vaccine approaches to prevent HIV acquisition and ongoing infection. This initiative emphasizes a Go/No-Go funding approach, requiring applicants to demonstrate measurable progress towards defined goals by the end of Year 2, with continued funding contingent upon meeting these criteria. The overall budget for this initiative is approximately $2 million for fiscal year 2024, with individual project budgets capped at $350,000 per year, and applications must be submitted via Grants.gov by August 2, 2025. For further inquiries, interested parties can contact NIH Grants Information at grantsinfo@nih.gov.
    HIV Vaccine Research and Design (HIVRAD) Program (P01 Clinical Trial Not Allowed)
    National Institutes of Health
    The National Institutes of Health (NIH) has announced a Notice of Funding Opportunity (NOFO) titled "HIV Vaccine Research and Design (HIVRAD) Program," aimed at advancing research for an effective prophylactic vaccine against HIV/AIDS. This grant encourages multi-disciplinary projects that address significant scientific questions in vaccine discovery, including preclinical evaluations in non-human primate models, while explicitly prohibiting clinical trials. The NIH plans to fund 1-2 awards totaling approximately $5 million for fiscal year 2025, with applications due by March 13, 2024, and an open submission date starting February 13, 2024. Interested applicants can reach out to NIH Grants Information at grantsinfo@nih.gov for further inquiries and are encouraged to review the detailed application guidelines available at https://grants.nih.gov/grants/guide/pa-files/PAR-24-037.html.
    Innovations to Optimize HIV Prevention and Care Continuum Outcomes (R21 Clinical Trial Optional)
    National Institutes of Health
    The National Institutes of Health (NIH) is inviting proposals for the R21 Exploratory/Developmental Research Grant under the funding opportunity titled "Innovations to Optimize HIV Prevention and Care Continuum Outcomes." This initiative aims to support innovative research that enhances HIV prevention and care strategies by exploring behavioral and social science approaches, new intervention methods, and implementation science, particularly addressing gaps in engagement, adherence, and retention in healthcare services. The grant, with a funding ceiling of $275,000 over two years, emphasizes collaboration with community organizations and the inclusion of diverse populations, aligning with national and global health objectives. Interested applicants can submit their proposals until January 9, 2026, and should direct inquiries to NIH Grants Information at grantsinfo@nih.gov.
    Early Stage Investigator HIV/AIDS Research Using Nonhuman Primate (NHP) Models (R21 Clinical Trial Not Allowed)
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a grant opportunity titled "Early Stage Investigator HIV/AIDS Research Using Nonhuman Primate (NHP) Models," aimed at supporting preclinical research on HIV/AIDS conducted by early-stage investigators with at least two years of postdoctoral experience. This funding initiative encourages innovative research approaches utilizing NHP models to develop next-generation therapies and strategies for HIV cure, aligning with the NIH Strategic Plan priorities for HIV research. Eligible applicants can request up to $200,000 in direct costs annually, with a total budget cap of $400,000 over two years, and must adhere to specific application procedures. The application deadline is September 7, 2025, and interested parties can reach out to NIH Grants Information at grantsinfo@nih.gov for further inquiries.
    DOD USAMRDC FY23-FY27 BROAD AGENCY ANNOUNCEMENT for Extramural Medical Research
    Dept. of the Army -- USAMRAA
    The Department of the Army, through the U.S. Army Medical Research and Development Command (USAMRDC), has announced the FY23-FY27 Broad Agency Announcement (BAA) for Extramural Medical Research, which is open for submissions from October 1, 2022, to September 30, 2027. This opportunity invites innovative research proposals that address critical military medical challenges, particularly in the areas of Military Infectious Diseases, Combat Casualty Care, and Military Operational Medicine, with a focus on enhancing medical practices for both military personnel and civilians. The BAA emphasizes the importance of collaboration with Department of Defense and Department of Veterans Affairs resources and requires adherence to strict submission guidelines via Grants.gov and the electronic Biomedical Research Application Portal (eBRAP). Interested applicants can submit pre-proposals at any time during the five-year period, with full proposals invited based on initial submissions, and should direct inquiries to the CDMRP Help Desk at help@eBRAP.org.
    Integration of HIV-related Services for Sustainability under PEPFAR
    Health Resources and Services Administration
    The Health Resources and Services Administration (HRSA) is forecasting a cooperative agreement opportunity titled "Integration of HIV-related Services for Sustainability under PEPFAR." This initiative aims to enhance the integration of HIV-related services with primary healthcare in select countries that are approaching HIV epidemic control, thereby sustaining the gains achieved through the PEPFAR program and contributing to resilient public health systems. The program is critical for improving public health outcomes and ensuring comprehensive care for individuals affected by HIV/AIDS and related health issues. HRSA anticipates awarding approximately $10 million across five grants, with the synopsis expected to be posted on April 1, 2024, and applications due by May 31, 2024. Interested applicants can reach out to Tola Life at tlife@hrsa.gov or by phone at (301)-443-1019 for further information.
    Ryan White HIV/AIDS Program (RWHAP) Web-Based Platform for HIV Tools and Resources
    Health Resources and Services Administration
    The Health Resources and Services Administration (HRSA) is inviting applications for the Ryan White HIV/AIDS Program (RWHAP) to develop a web-based platform aimed at enhancing access to HIV care resources and improving treatment outcomes for individuals living with HIV. The project will create a centralized repository for evidence-based interventions, best practices, and training resources, targeting healthcare professionals, stakeholders, and the general public. This initiative is critical for facilitating better health outcomes and reducing HIV transmission through innovative resource access and strategic collaborations. Eligible applicants include a variety of domestic organizations, with an estimated total program funding of $900,000 available for one award, and applications are due by March 18, 2025. For further information, interested parties can contact Nikia Crollard at Ncrollard@hrsa.gov or by phone at (301) 443-3577.